The opinions of injecting drug user (idus) hiv patients and health professionals on access to antiretroviral treatment and health services in valencia, spain

Evaluation and the Health Professions

Volumn 34, Issue 3, 2011, Pages 349-361

  de la Hera, Manuela Garcia ^a,c   Davo, Maria Carmen ^b   Ballester Añón, Rosa ^b   Vioque, Jesus ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

access health services; adherence treatment; HIV AIDS; IDUs; qualitative research

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; DRUG USE; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; PATIENT; PSYCHOLOGICAL ASPECT; SPAIN; SUBSTANCE ABUSE;

ADULT; ANTI-RETROVIRAL AGENTS; DRUG USERS; FEMALE; HEALTH PERSONNEL; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENTS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 80053235853     PISSN: 01632787     EISSN: 15523918     Source Type: Journal    
DOI: 10.1177/0163278711401743     Document Type: Article

References (20)

1. Barfod T.,Hecht F.,Rubow C.,Gerstoft J.Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: A qualitative study using grounded theory.BMC Health Services Research. 2006;6:154-156.
2. Carrieri M.,Moatti J.,Vlahov D.,Obadia Y.,Reynaud-Maurupt C.,Chesney M.Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use. MANIF 2000 Study Group.Journal of Epidemiology and Community Health. 1999;53:4-8.
3. Cunningham C.,Sohler N.,Korin L.,Gao W.,Anastos K.HIV status, trust in health care providers, and distrust in the health care system among Bronx women.AIDS Care. 2007;19:226-234.
4. Fumaz C.,Muñoz-Moreno J.,Moltó J.,Ferrer M.,López-Blázquez R.,Negredo E.,Clotet B.Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: Attitudes and beliefs.AIDS Care. 2008;20:796-805.
5. García de la Hera M.,Ruiz I.,Pérez-Hoyos S.,Hernández Aguado I.Health services utilization according to gender in a cohort of intravenous drug users infected with HIV.Medicina Clinica (Barc). 2003;120:489-493.
6. Knowlton A.,Arnsten J.,Eldred L.,Wilkinson J.,Gourevitch M.,Shade S.Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users.Journal of Acquired Immune Deficiency Syndrome. 2006;41:486-492.
7. Lert F.,Kazatchkine M.Antiretroviral HIV treatment and care for injecting drug users: An evidence-based overview.International Journal of Drug Policy. 2007;18:255-261.
8. Lima M.,Costa J.,Figueiredo W. S.,Schraiber L.Invisibility of drug use and support for professionals of the AIDS services.Revista de Saúde Pública. 2007;41:6-13.
9. Malta M.,Strathdee S.,Magnanini M.,Bastos F.Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review.Addiction. 2008;103:1242-1257.
10. Berlin: VERBI Software.Consult.Sozialforschung. GmbH; 2005:.
11. Sabin L.,Desilva M.,Hamer D.,Keyi X.,Yue Y.,Wen F.,Gill C. J.Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: A qualitative study.AIDS Care. 2008;20:1242-1250.
12. Schneider J.,Kaplan S.,Greenfield S.,Li W.,Wilson I.Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection.Journal of General Internal Medicine. 2004;19:1096-1103.
13. Small W.,Wood E.,Betteridge G.,Montaner J.,Kerr T.The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: A qualitative study.AIDS Care. 2009;21:708-714.
14. Strauss A.,Corbin J.Basics of qualitative research: Grounded theory procedures and techniques. London and Newbury Park, NJ: SAGE; 1990:.
15. Tugenberg T.,Ware N.,Wyatt M.Paradoxical effects of clinician emphasis on adherence to combination antiretroviral therapy for HIV/AIDS.AIDS Patient Care and STDs. 2006;20:269-274.
16. Vervoort S.,Borleffs J.,Hoepelman A.,Grypdonck M.Adherence in antiretroviral therapy: a review of qualitative studies.AIDS. 2007;21:271-281.
17. Volkow N. D.,Montaner J.Enhanced HIV testing, treatment, and support for HIV-infected subtance users.Journal of the American Medical Association. 2010;303:1423-1424.
18. Ware N.,Wyatt M.,Tugenberg T.Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.Social Science and Medicine. 2005;61:565-576.
19. Wood E.,Kerr T.,Tyndall M.,Montaner J.A review of barriers and facilitators of HIV treatment among injection drug users.AIDS. 2008;22:1247-1256.
20. Wood E.,Montaner J.,Tyndall M.,Schechter M.,O'Shaughnessy M.,Hogg R.Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.Journal of Infectious Disease. 2003;188:1164-1170.